Zheng-Zheng Yu

BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti‐PD‐1/PD‐L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity

Zhiyong Cai, Jinbo Chen, Zheng-Zheng Yu et al. · Advanced Science · 2023 · 68 citations · Full text

Medicine, Immunology, Oncology +17

ANXA1 Binds and Stabilizes EphA2 to Promote Nasopharyngeal Carcinoma Growth and Metastasis

Juan Feng, Shanshan Lu, Ta Xiao et al. · Cancer Research · 2020 · 57 citations

Medicine, Cancer Biology, Oncology +15

ANXA1 Promotes Tumor Immune Evasion by Binding PARP1 and Upregulating Stat3-Induced Expression of PD-L1 in Multiple Cancers

Xiao Ding, Ting Zeng, Zhu Wei et al. · Cancer Immunology Research · 2023 · 55 citations

Medicine, Immunology, Oncology +17

ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers

Zheng-Zheng Yu, Yun-Ya Liu, Wei Zhu et al. · Journal for ImmunoTherapy of Cancer · 2023 · 43 citations · Full text

Medicine, Immunology, Oncology +17

HDAC7 promotes the oncogenicity of nasopharyngeal carcinoma cells by miR-4465-EphA2 signaling axis

Qiguang Li, Ta Xiao, Wei Zhu et al. · Cell Death and Disease · 2020 · 40 citations · Full text

Medicine, Cancer Biology, Oncology +15